Correct. The main focus of the company right now i
Post# of 30028
Posted On: 01/17/2015 11:53:18 AM
Correct. The main focus of the company right now is to get BP on board to fully employ Lympro as the de facto diagnostic when enrolling patients into their clinical trials. Once the value of Lympro is ascertained, it should be off to the races for AMBS. The issue is when does that happen?
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
Scroll down for more posts ▼